This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beijing Molecule Science and Technology Co., Ltd.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovations of Xinghai Ma
Introduction
Xinghai Ma is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health issues. His work focuses on innovative solutions for treating diabetes and related conditions.
Latest Patents
Xinghai Ma holds a patent for "N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase IV and the pharmaceutical uses thereof." This invention relates to N-Substituted thiomorpholine compounds that serve as inhibitors of dipeptidyl peptidase IV (DPP-IV). The patent outlines a method for preparing these compounds, which can be used in pharmaceutical compositions aimed at treating and preventing diabetes, hyperglycemia, and other diseases influenced by the immune system. He has 1 patent to his name.
Career Highlights
Xinghai Ma is associated with Beijing Molecule Science and Technology Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on public health, particularly in managing diabetes and obesity.
Collaborations
Xinghai Ma collaborates with notable colleagues, including Junhai Xiao and Song Li. Their combined expertise contributes to the innovative research and development at their company.
Conclusion
Xinghai Ma's contributions to the field of pharmaceuticals highlight the importance of innovation in addressing critical health challenges. His work exemplifies the potential of scientific research to improve lives through effective medical solutions.